"Biotechnology and pharmaceutical companies are often driven by profit goals, but the case studies in Bioindustry Ethics show that this is increasingly not at the expense of ethical integrity. ...lend[s] important insights to other executives and professionals who might be developing their own practices and policies."- GENOMICS & PROTEOMICS (August 2005)

• Chapter 1: INTRODUCTIONChapter 2: MERCK: STAYING THE COURSEChapter 3: GENZYME: PUTTING PATIENTS FIRSTChapter 4: MILLENNIUM PHARMACEUTICALS, INC.: CREATING AND SUSTAINING CORPORATE VALUESChapter 5: MAXIM PHARMACEUTICALS (A): INTERNAL AND EXTERNAL DIALOGUESChapter 6: DIVERSA INC.: ETHICAL ISSUES IN BIOPROSPECTING PARTNERSHIPSChapter 7: PIPELINE BIOTECH A/S: COMPETING REGULATORY REGIMES FOR LABORATORY ANIMAL EXPERIMENTSChapter 8: TGN BIOTECH: A START-UP WITH ETHICAL ROOTSChapter 9: INTERLEUKIN GENETICS AND ALTICOR: AN UNLIKELY PARTNERSHIPChapter 10: SCIONA LTD.: A PIONEER IN NUTRIGENOMICS: THE PATH TO CONSUMER ACCEPTANCEChapter 11: AFFYMETRIX, INC.: USING CORPORATE ETHICS ADVICEChapter 12: PHARMASNPS INC.: CREATING AN ETHICS ADVISORY BOARDChapter 13: MONSANTO COMPANY: BIO-AGRICULTURE PIONEERChapter 14: NOVO NORDISK: THE TRIPLE BOTTOM LINEChapter 15: CONCLUSION: LESSONS FOR COMPANIES AND FUTURE ISSUESINDEX